Treatment of cone photoreceptors is of relevance because mutations in CRX also cause milder adult-onset cone-rod dystrophies and macular dystrophies, which could potentially benefit from gene therapy treatment described here. This evidence concerns the gene CRX and Cone rod dystrophy.